Pages
Products

Luciferase Reporter Cell Line - C666-1

For research use only. Not intended for any clinical use.

Cat. No. :   CSC-RR01183

Host Cell :   C666-1 Size :   >1x106 frozen cells/vial

Inquire for Price

Cell Line Information

Cell Culture Information

Safety and Packaging

Gene Information

Cat. No. CSC-RR01183
Description This cell line is engineered to stably exprress Luciferase reporter gene in C666-1 cells. It is a useful tool for bioluminescent tracking of C666-1 cells.
Product Type Bioluminescent Reporter Cell Lines
Target Gene Luciferase
Host Cell C666-1
Host Cell Species Homo sapiens (Human)
Applications in vitro cell tracking and in vivo cell imaging
Size One vial of frozen cells, typically >1x10^6cells/vial
Stability This cell line is stable at least 10 passages.
Storage Liquid nitrogen
Shipping Dry ice
Revival Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media.
Growth Properties Adherent cell line
Mycoplasma Negative
Format One frozen vial containing millions of cells
Storage Liquid nitrogen
Safety Considerations The following safety precautions should be observed.
1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum.
2. No eating, drinking or smoking while handling the stable line.
3. Wash hands after handling the stable line and before leaving the lab.
4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells.
5. All waste should be considered hazardous.
6. Dispose of all liquid waste after each experiment and treat with bleach.
Ship Dry ice
Target Gene Luciferase
Quick Inquiry

Background

Case Study

Q & A

Customer Reviews

The C666-1 cell line is a well-established and widely used cell model in cancer research, specifically derived from nasopharyngeal carcinoma (NPC). This epithelial cell line was originally isolated from a recurrent nasopharyngeal tumor and is highly valuable due to its persistent expression of Epstein-Barr virus (EBV) antigens, a characteristic feature of NPC tumors. Unlike many other NPC cell lines, C666-1 cells maintain EBV episomes and express latent EBV genes such as LMP1, LMP2A, and EBNA1, making it a biologically relevant tool for studying EBV-driven tumorigenesis. These cells exhibit adherent growth characteristics and retain typical epithelial cell morphology, allowing researchers to study tumor cell behavior, metastasis, and treatment responses.

The luciferase reporter cell line – C666-1 utilizes the characteristics of the parental cell line and incorporates a luciferase gene construct, enabling quantitative real-time monitoring of specific biological activities. Its applications span multiple fields: in drug discovery, it facilitates high-throughput screening of compounds by measuring changes in luminescence intensity, indicating pathway activation or inhibition. For example, researchers use it to evaluate inhibitors targeting EBV-mediated oncogenic signaling or immunomodulatory agents. In mechanistic studies, this cell line helps decipher the transcriptional regulatory mechanisms of genes involved in metastasis, apoptosis, or inflammation by linking luciferase activity to promoter dynamics.

Mouse orthotopic xenograft tumor models are frequently utilized to investigate the mechanisms underlying tumorigenesis, tumor progression, and preclinical therapeutic interventions. However, there remains a lack of established and highly visualizable orthotopic xenograft models for nasopharyngeal carcinoma (NPC), which hinders the development of therapeutic strategies for this malignancy. In this study, researchers aimed to establish a simple and reliable method for constructing an orthotopic xenograft model of NPC. They subcutaneously injected human NPC cells (C666–1-luc)-which stably express the firefly luciferase gene-into the right axillary region of BALB/c nude mice. Four weeks later, the resulting subcutaneous tumors were excised, sectioned into small fragments, and orthotopically transplanted into the nasopharyngeal region of immunodeficient BALB/c nude mice to induce tumor formation. Tumor growth was monitored using bioluminescence imaging and small-animal magnetic resonance imaging (MRI). Furthermore, histological features and the expression of relevant immunological antigens within the orthotopic NPC xenograft model were analyzed using tissue section analysis and immunohistochemistry (IHC). This study successfully established a visualizable orthotopic xenograft model of NPC. Fluorescence signal detection, micro-MRI imaging, and Hematoxylin-Eosin (HE) staining results confirmed that tumors had successfully grown within the nasopharyngeal region of the nude mice. Additionally, IHC analysis revealed the expression of cytokeratin (CK), CK5/6, P40, and P63 within the orthotopic tumor tissues.

First, researchers constructed human nasopharyngeal carcinoma cells that stably express the firefly luciferase gene (C666-1-luc) (Figure 1a). Subsequently, in vitro and in vivo imaging analyses were performed on both C666-1 and C666-1-luc cells. In the in vitro experiments, C666-1-luc cells exhibited distinct regions of high-intensity luminescence, whereas no such phenomenon was observed in the C666-1 cells (Figure 1b). Three weeks after the subcutaneous injection of C666-1-luc cells into the axillae of mice, in vivo imaging was conducted on the mice bearing subcutaneous tumors. The results revealed that the subcutaneous tumor regions displayed prominent, high-intensity luminescent signals, and the spatial extent of these luminescent regions corresponded precisely with the actual size of the subcutaneous tumors (Figure 1c). Next, the researchers implanted tissue fragments of the luciferase-expressing C666-1-luc cells-which had already formed subcutaneous tumors-into the nasopharyngeal regions of nude mice, thereby establishing an orthotopic xenograft model of nasopharyngeal carcinoma. Following the transplantation of the tumors into the nasopharynx of the nude mice, bioluminescence imaging (BLI) results demonstrated that the tumor regions within the nasopharyngeal cavity emitted strong, stable, and high-intensity luminescent signals. The high-intensity luminescent regions-representing the tumors-gradually expanded over time, indicating that the tumors were undergoing continuous growth within the nasopharynx of the nude mice (Figure 1d). Subsequently, a longitudinal quantitative analysis of the nasopharyngeal carcinoma BLI signals acquired at various time points was performed using the "Region of Interest" (ROI) analysis method. The results demonstrated an upward trend in the intensity of the nasopharyngeal carcinoma BLI signals over time, thereby further corroborating the continuous growth of the tumors (Figure 1e).

Figure 1. Establishment of the mouse orthotopic xenograft model of nasopharyngeal carcinoma.Figure 1. Establishment of the mouse orthotopic xenograft model of nasopharyngeal carcinoma. (Chen W, et al., 2024)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
High Signal, Zero Hassle

The C666-1 luciferase line from Creative Biogene delivered a strong, linear luminescent response in our promoter assays with minimal background. Cells revived quickly, expanded uniformly, and stayed stable over multiple passages.

French

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction